Canada markets open in 4 hours 7 minutes

Newron Pharmaceuticals S.p.A. (NWRN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
9.83+0.23 (+2.40%)
As of 11:07AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
5,921
9,057
6,094
5,762
5,258
-
Cost of Revenue
-
-
-
-
295
1,425
Gross Profit
-
-
-
-
4,963
5,613
Operating Expenses
Research Development
9,266
13,152
12,005
10,725
14,853
-
Selling General and Administrative
3,647
4,062
3,617
3,531
4,043
-
Total Operating Expenses
16,843
20,686
19,396
18,119
23,324
-
Operating Income or Loss
-10,922
-11,629
-13,302
-12,357
-18,066
-
Interest Expense
3,518
4,168
3,947
2,918
2,239
-
Income Before Tax
-14,457
-16,200
-17,472
-14,884
-19,618
-
Income Tax Expense
17
24
21
17
1,380
-
Income from Continuing Operations
-14,474
-16,224
-17,493
-14,901
-20,998
-
Net Income
-14,474
-16,224
-17,493
-14,901
-20,998
-
Net Income available to common shareholders
-14,474
-16,224
-17,493
-14,901
-20,998
-
Basic EPS
-0.89
-0.91
-0.98
-0.84
-1.18
-
Diluted EPS
-0.89
-0.91
-0.98
-0.84
-1.18
-
Basic Average Shares
17,845
17,845
17,845
17,845
17,845
-
Diluted Average Shares
17,845
17,845
17,845
17,845
17,845
-